The purpose of this study is to evaluate Zilebesiran in patients with Hypertension not adequately controlled and with either established cardiovascular disease or high risk for cardiovascular disease.
Contact phone
Sparrow Clinical Research Institute | 517.364.5760
Contact email
[email protected]
Principal investigator
Dr. John Ip, MD
Trial Category
Heart & Vascular
Trial SubCategory
Cardiovascular Disease
Webform